Hyper Terminal logo
Company earnings

LIN Earnings Date & History

Linde PLC (NASDAQ NMS - GLOBAL MARKET) earnings schedule, consensus estimates and reported results for the last eight quarters.

Last updated Oct 28, 2026 at 6:39 PM ET

Linde PLC

Chemicals

Next earnings date
Thursday, October 29, 2026
Reporting session
Before Open
EPS estimate
$4.56
Revenue estimate
$9.23B

Research beyond the earnings headline

What’s happening around LIN?

Congressional Trading

Review purchases and sales when available, transaction and disclosure dates kept separate

Members-only details

Previews show an example layout only, not data for LIN. Coverage varies by company.

LIN earnings history

Report dateQuarterEPS est.EPS actualSurpriseRevenue
Friday, July 31, 2026Q2 2026$4.53$4.50-0.6%$9.29B
Friday, May 1, 2026Q1 2026$4.31$4.33+0.5%$8.78B
Thursday, February 5, 2026Q4 2025$4.22$4.20-0.4%$8.76B
Friday, October 31, 2025Q3 2025$4.22$4.21-0.2%$8.62B

What the market is watching in LIN's next report

  • The full Earnings Read for this company: focus areas, peer read-through and prior-reaction context.
  • Ticker Read combines trend, relative strength and catalysts in one research view.
  • Scanners, daily catalyst context and the members-only Weekly Watchlist are included.
Free by email

Get the week's earnings by email

One free email each week: the reports that matter, when they land, and what the market is watching.

No account required. Unsubscribe any time. Research and education only, not investment advice.

Frequently asked questions

Calendar data is provided for educational and research purposes only and is not investment advice. Release dates, times, estimates and results can change; always verify against the issuing company or agency.

LIN earnings discussion

Anyone can read. Any free Hyper Stocks account can join in.

Create a free account to join the discussion. Reading is open to everyone, commenting is free, no subscription needed.

Loading discussion…

Member comments are opinions from individual users, not Hyper Stocks research, and are never personalised investment advice.